Works matching IS 14642662 AND DT 2000 AND VI 1 AND IP 3
Results: 86
Commentary on the summary of the French Guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 132, doi. 10.1046/j.1468-1293.2000.00017.x
- By:
- Publication type:
- Article
New French guidelines for antiretroviral treatment.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 133
- By:
- Publication type:
- Article
How generalizable are the results of large randomized controlled trials of antiretroviral therapy?
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 149, doi. 10.1046/j.1468-1293.2000.00019.x
- By:
- Publication type:
- Article
A simple, once-daily dosing regimen for treating HIV-1 infection in intravenous drug users.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 162, doi. 10.1046/j.1468-1293.2000.00020.x
- By:
- Publication type:
- Article
A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 164, doi. 10.1046/j.1468-1293.2000.00021.x
- By:
- Publication type:
- Article
Disseminated infection due to Encephalitozoon cuniculi in a patient with AIDS: case report and review.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 155, doi. 10.1046/j.1468-1293.2000.00022.x
- By:
- Publication type:
- Article
Management of HIV and pregnancy in England's North Thames Region 1999: a survey of practice in 21 hospitals.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 143, doi. 10.1046/j.1468-1293.2000.00023.x
- By:
- Publication type:
- Article
O1 Compartmentalization of resistance mutations in HIV-1 between the lung and peripheral blood.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 166, doi. 10.1046/j.1468-1293.2000.00024-1.x
- By:
- Publication type:
- Article
010 Quadruple HAART in primary infection: results from QUEST.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 168
- By:
- Publication type:
- Article
011 The viral response to HAART over the first 16 weeks of therapy according to the pre-HAART and the 4–8-week viral load.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 169, doi. 10.1046/j.1468-1293.2000.00024-21.x
- By:
- Publication type:
- Article
012 AIDS-related lymphoma in the era of HAART.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 169, doi. 10.1046/j.1468-1293.2000.00024-23.x
- By:
- Publication type:
- Article
013 Normalization of intestinal permeability following antiretroviral therapy in HIV+ patients with diarrhoea.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 169, doi. 10.1046/j.1468-1293.2000.00024-25.x
- By:
- Publication type:
- Article
014 Does TB treatment alter virological and immunological response to HAART?
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 170, doi. 10.1046/j.1468-1293.2000.00024-27.x
- By:
- Publication type:
- Article
015 Rapid onset lipodystrophy syndrome (LD) in three patients with prior severe nucleoside toxicity.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 170, doi. 10.1046/j.1468-1293.2000.00024-29.x
- By:
- Publication type:
- Article
016 Type III hyperlipidaemia, related to PI treatment, is not caused by homozygosity for apoE2.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 170, doi. 10.1046/j.1468-1293.2000.00024-31.x
- By:
- Publication type:
- Article
017 A prospective study of lipid metabolism in HIV-1-seropositive patients treated with HAART.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 171, doi. 10.1046/j.1468-1293.2000.00024-33.x
- By:
- Publication type:
- Article
O18 A dichotomy in CD4 T-cell responses specific to HIV antigens.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 171, doi. 10.1046/j.1468-1293.2000.00024-35.x
- By:
- Publication type:
- Article
O19 CD4+ T–cell responses in early HIV infection.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 171, doi. 10.1046/j.1468-1293.2000.00024-37.x
- By:
- Publication type:
- Article
O2 Comparison of viral drug resistance, adherence and PK indices in patients on successful and failing PI-based regimens.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 166, doi. 10.1046/j.1468-1293.2000.00024-3.x
- By:
- Publication type:
- Article
020 Antibody responses to HIV Gag and Env following highly active antiretroviral therapy (HAART).
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 172, doi. 10.1046/j.1468-1293.2000.00024-39.x
- By:
- Publication type:
- Article
021 Assessment of thymic activity by positron emission tomography in HIV patients on HAART.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 172, doi. 10.1046/j.1468-1293.2000.00024-41.x
- By:
- Publication type:
- Article
022 A heterosexual outbreak in Doncaster involving subtype B of HIV-1: molecular epidemiology as a supplement to contact tracing.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 172, doi. 10.1046/j.1468-1293.2000.00024-43.x
- By:
- Publication type:
- Article
023 Undiagnosed symptomatic acute HIV infections: a 12-month retrospective analysis of cases in South London.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-45.x
- By:
- Publication type:
- Article
024 Mortality in the HAART era.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-47.x
- By:
- Publication type:
- Article
O3 Which are the most clinically useful questions in assessing adherence (AD)? A prospective comparative study.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 166, doi. 10.1046/j.1468-1293.2000.00024-5.x
- By:
- Publication type:
- Article
O4 A novel point mutation assay for the detection of resistance to non-nucleoside reverse transcriptase inhibitors.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-7.x
- By:
- Publication type:
- Article
O5 Genotypic drug-resistance testing in early HIV infection.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-9.x
- By:
- Publication type:
- Article
O6 Genotypic resistance mutations and virological response to combination therapy in a clinical cohort.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-11.x
- By:
- Publication type:
- Article
O7 Structural solution of the HIV-1 packaging signal and use of RNA transcripts containing the signal as potential antiviral molecules.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-13.x
- By:
- Publication type:
- Article
O8 HIV post-exposure prophylaxis (PEP): a retrospective review.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 168, doi. 10.1046/j.1468-1293.2000.00024-15.x
- By:
- Publication type:
- Article
09 One-year UK experience of nelfinavir in paediatric HIV-1.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 168, doi. 10.1046/j.1468-1293.2000.00024-17.x
- By:
- Publication type:
- Article
P1 Assessing the role of treatment adherence in a clinical setting.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-49.x
- By:
- Publication type:
- Article
P10 The relationships between ethnicity, gender, risk factor and viral load (VL) in HIV-1 antiretroviral naive patients.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 176, doi. 10.1046/j.1468-1293.2000.00024-67.x
- By:
- Publication type:
- Article
P11 Access to HIV medical services by HIV-positive black Africans in London.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 176, doi. 10.1046/j.1468-1293.2000.00024-69.x
- By:
- Publication type:
- Article
P12 Uptake of antiretroviral therapy by African patients in a District General Hospital.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 176, doi. 10.1046/j.1468-1293.2000.00024-71.x
- By:
- Publication type:
- Article
P13 Assessing health-related quality-of-life in individuals with HIV/AIDS in the era of HAART.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 177, doi. 10.1046/j.1468-1293.2000.00024-73.x
- By:
- Publication type:
- Article
P14 A preliminary cost analysis of management options for individuals with prior history of CMV disease.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 177, doi. 10.1046/j.1468-1293.2000.00024-73.x
- By:
- Publication type:
- Article
P15 Survival of patients with AIDS 1983–99.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 177, doi. 10.1046/j.1468-1293.2000.00024-77.x
- By:
- Publication type:
- Article
P16 Dual nucleoside therapy in the era of HAART.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 177, doi. 10.1046/j.1468-1293.2000.00024-79.x
- By:
- Publication type:
- Article
P17 Response of individuals with high viral load to non-nucleoside reverse transcriptase inhibitors.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 178, doi. 10.1046/j.1468-1293.2000.00024-81.x
- By:
- Publication type:
- Article
P18 Comparison of combination antiretroviral chemotherapy in patients with low initial CD4 counts.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 178, doi. 10.1046/j.1468-1293.2000.00024-83.x
- By:
- Publication type:
- Article
P19 Response to second-line protease-inhibitor (PI) regimens: results from the EuroSIDA study.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 178, doi. 10.1046/j.1468-1293.2000.00024-85.x
- By:
- Publication type:
- Article
P2 DAART –- a 1-year review.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-51.x
- By:
- Publication type:
- Article
P20 Triple protease inhibitor combinations in patients with multidrug resistant HIV infection.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 179, doi. 10.1046/j.1468-1293.2000.00024-87.x
- By:
- Publication type:
- Article
P21 Prevalence of antiretroviral resistance mutations in treatment-naive HIV-1-infected patients in South London.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 179, doi. 10.1046/j.1468-1293.2000.00024-89.x
- By:
- Publication type:
- Article
P22 AZT genotypic resistance in patients not exposed to AZT.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 179, doi. 10.1046/j.1468-1293.2000.00024-91.x
- By:
- Publication type:
- Article
P23 Resistance testing by population sequencing is not reproducible for mixed populations.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 180, doi. 10.1046/j.1468-1293.2000.00024-93.x
- By:
- Publication type:
- Article
P24 HIV resistance testing on archived samples aids current therapeutic decisions.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 180, doi. 10.1046/j.1468-1293.2000.00024-95.x
- By:
- Publication type:
- Article
P25 The relationship between ARV drug levels, drug resistance, adherence and treatment failure in a routine clinical setting.
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 180, doi. 10.1046/j.1468-1293.2000.00024-97.x
- By:
- Publication type:
- Article
P26 The feasibility of therapeutic drug monitoring (TDM) for HIV protease inhibitors (PIs).
- Published in:
- HIV Medicine, 2000, v. 1, n. 3, p. 180, doi. 10.1046/j.1468-1293.2000.00024-99.x
- By:
- Publication type:
- Article